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            Regioselective hydroxylation at the C-11 position of ent-kaurene (5) was achieved via radical cycliza-
         tion of the hydroxy group at the C-17 position. Naturally occurring ent-lla-hydroxykauren-15-one (3) 
         was synthesized from the hydroxylated kaurene 4 in two steps. 
             KEY WORDS: Hydroxylation/ ent-Kaurene/ ent-lla-Hydroxykaurene/ nt-11a,15j9-
                             Dihydroxykaurene/ ent-1 la-Hydroxykauren-15-one/Radical Cycli-
                           zation/ Lead Tetraacetate/ Tosylhydrazone/ 
           In the course of our investigation on thephysiologically active diterpenoids, we found that 
ent-15j9-hydroxykaur-16-ene (1) had a potent stimulating effect on corticosterone production in 
       isolated rat adrenal cells') and that poly hydroxylated kaurenoids uch asoridonin (2) showed 
        strong antitumor activity against. Ehrlich asites carcinoma in mice.2lThese findings timu-
       lated our interset into investigating the steroidogenic effect of varioushydroxykaurenes and the 
        antitumor effect of various hydroxykaurenones, because it is anticipatedthat the hydroxy group 
       in the kaurene skeleton plays an important role in the action of physiologically active 
         kaurenoids. 
           In oder to prepare various hydroxykaurenoids, we recently succeeded in regioselective 
        hydroxylations ofthe unactivated carbon atoms (C-7, —9, —12 and—14) on the B and C rings 
        in the kaurene skeletone through radical cyclization of a hydroxymethyl group on the D ring.3l 
        Though a report concerning the hydroxylation of the C-11 positionon the kaurene has already 
        been published by Kato and coworkers,4l the synthetic method forthe preparation of ent-1 la-
        hydroxykauren-15-one (3)by Kato requires comparatively ong synthetic steps (total 11 steps 
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from kaurene). No report on the synthesis of ent-11a-hydroxykaurene (4) has appeared to 
date. Here we report the convenient short syntheses of ent-1 la-hydroxykauren-15-one (3) and 
ent-lla-hydroxykaurene (4) from ent-kaurene (5). 
   A method for the transformation of kaurene (5) into the lactone 6 was published by 
McCrindle5) and Kato,4) respectively (Scheme I). However, radical cyclization of the alcohol 
7 into the cyclic ether 8 proceeded in a yield of less than 41% according to thier method. The 
yield was improved to 80% by the use of the modified reaction conditions (See experimental 
section). 
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                                           SchemeI
   The transformation of the lactone 6 into the hydroxykaurenone 3 via 4 is shown in Scheme 
II. Thus, reduction of the lactone 6 with diisobutyl aluminum hydride gave a mixture of 
epimeric hemiacetals 9, which was converted to the tosylhydrazone 10 in 70% overall yield by 
the treatment with tosylhydrazone in the presence of acetic acid. The configuration of 
hydrazone moiety in the structure of 10 was considered to be a /3-configuration because the 
torsional strain between the 13-hydrogen and the 17-carbon atom6) prevents the inversion of the 
configuration from (3 to a under the reaction conditions. The attempted Shapiro reaction') on 
the hydrazone 10 with n-butyl lithium (execss) did not afford the desired kaurenol 4, but the 
butylated product 11.8) On the other hand, use of lithium diisopropylamide which is a 
non-nucleophilic base gave the intended product 4 in low yield (16%). Several non-
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   Allylic oxidation of kaurenol 4 by Sharpless method9l proceeded smoothly to give dihyd-
roxykaurene 12 resulting from the less hindered a-side attack of the reagent. Subsequent 
oxidation of the allylic alcohol 12 with manganese dioxide afforded the a,/9-unsaturated ketone 
3, which was identified with naturally occuring ent-11a-hydroxykauren-15-one101 by the com-
parison of the spectroscopic data. 
   Investigation of the physiological activity of synthesized 11-hydroxykaurene and its deriva-
tives is now in progress. 
                       EXPERIMENTAL SECTION 
   Infrared (IR) spectra were recorded with a Hitachi 215 spectrophotometer or a JASCO A-
202 spectrophotometer, and 1H—NMR spectra were obtained with JEOL FX-400 spectrometer. 
Chemical shift are reported relative to internal tetramethylsilane. Mass spectra (MS) were 
determined on a JEOL JMS—O 1 SG double-focusing mass spectrometer or a JEOL JMS—DX 
300 mass spectrometer. Melting points were determined with a Yanagimoto apparatus and 
are uncorrected. 
    ent-kaurene (5) isolated from the leaves of Cryptomeria japonica1) was converted to the 
kauranol 7 by the hydroboration-oxidation reaction.1~1 
Radical Cyclization of Kauranol 7 with Lead Tetraacetate 
   A solution of 7 (301 mg) and lead tetraacetate (12.5 g) in dry cyclohexane was stirred with 
refluxing under irradiation with 100 W tungsten lamp until kauranol on TLC disappeared (ca. 
2.5 h). After filtration, the residue was washed with ether. The combined organic layer was 
washed with aqueous sodium thiosulfate and brine successively. After being dried over 
Na2SO4, the solvent was evaporated in vacuo and the residue was chromatographed on silica gel 
column to give the cyclic ether 8 (249 mg, 80% yield).51 
ent-(16R)-Kauran-17,11a-olide (6) 
   To a solution of 8 (4.51 g) in a mixture of carbon tetrachloride (35 ml) and acetonitrile (35 
ml) were added aqueous sodium periodate (13.5 g in 50 ml water) and ruthenium trichloride 
(32 mg). The mixture was vigorously stirred for 2.5 h at room temperature. After being 
quenched with iso-propanol to destroy remaining RuO4i the reaction mixture was diluted with 
water. The extract with dicholromethane was treated as usual to give a crude product, which 
was chromatographed on silica gel column to afford lactone 65) (4.25 g, 90% yield), mp 177-
178°C, 
Tosylhydrazone 10 
   To a solution of 6 (45.8 mg) in dry tetrahydrofuran (2.5 ml) was added hexane solution 
(2.5 ml) of 20% diisobutylaluminium hydride, and the mixture was stirred for 1 h at 0°C. 
After being quenched with water, the reaction mixture was filtered with celite. ° The filtrate 
was evaporated to give a crude crystalline product (72 mg) which contained epimeric mixture of 
9. To a solution of the crude 9 dissolved in dichloromethane (1 ml) and acetic acid (1 ml) was 
added tosylhydrazone (83 mg) and the mixture was stirred at room temperature for 2.5 h. The 
reaction mixture was then poured into cold aqueous solution of sodium bicarbonate. Usual 
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work up including extraction with ethyl acetate gave a crude material (126.5 mg) which was 
chromatographed on the silica gel column to yield tosylhydrazone 10 (50.7 mg, 70%), colorless 
powder from hexane—ethyl acetate, mp 161.5-162.5°C. IRumaxcm-1 (CHC13): 3320, 1714 
and 1610. 1H-NMR 8 (CDC13): 7.81, 7.30 (each 2H, q of AB type, J=8 Hz, Aromatic-H), 
6.40 (1H, s, N-H), 4.26 (1H, d, changed to singlet by D2O, J=11 Hz, 11-H), 4.06 (1H, s, 17-
H), 3.85 (1H, d, J=11 Hz, -OH), 2.43 (3H, s, Ar-CH3), 0.92, 0.85 and 0.81 (each 3H, s, 3 X 
CH3), Anal. Calcd for C27H40O3N2S: C, 68.61; H, 8.51; N, 5.93. Found: C, 68.93; H, 8.65; 
N, 5.91. 
Shapiro Reaction with Tosylhydrazone 10 
   To a solution of 10 (20.3 mg) in dry ether (1.5 ml) was added n-butyl lithium (1.5 M THE 
solution, 0.25 ml) and the mixture was stirred at room temperature for 1 h. Usual work up of 
the extract gave a crude substance which was chromatographed on the silica gel column to give 
butyulated compound 11 (10.1 mg, 67%) as oil. IRvmax cm-1 (CHC13): 3600, 3450, 1455, 
1395 and 965. 1H-NMR S (CDCI3): 3.86 (1H, d, J=6.6 Hz, 11-H), 2.03 (1H, m), 0.88, 0.85 
and 0.78 (each 3H, s, 3XCH3). High-resolution MS m/z; M+ Calcd for C24H42O: 346.3234. 
Found: 346.3233. 
ent-11a-Hydroxykaurene (4) 
   To a solution of tosylhydrazone 10 (23.1 mg) in dry ether (1 ml) was added an ether 
solution of lithium diisopropylamid (0.75 M, 0.5 ml) and the mixture was stirred at room 
temperature for 1.5 h. Usual work up of the extract gave a crude substance, which was 
chromatographed on the silica gel column to separate kaurenol 4 (2.3 mg, 16%), colorless 
powder from methanol — ethy acetate, mp 131-132°C. 1H-NMR 6 (CDC13): 5.03, 4.85 (each 
1H, s, 17-H2), 3.87 (1H, br s, 11-H), 2.70 (1H, br s, 13-H), 0.90, 0.88 and 0.81 (each 3H, s, 
3XCH3). MSm/z; 288 (Mt), and 270 (M+-H2O). 
ent-1la,15/3-Dihydroxykaurene (12) 
   To a solution of SeO2 (11.0 mg) in CH2C12 (1 ml) was added 75 pl of 70% aqueous 
tert-butyl hydroperoxide. After the mixture had been stirred for 1 h at room tepmperature, a 
solution of kaurenol 4 (50 mg) in dicholromethane (3 ml) was added and the mixture was 
stirred for 1.5 h at room temperature. After being quenched with aqueous sodium thiosul-
phate, usual work up of the extract gave an oily substance (70.8 mg), which was chromatog-
raphed on a silica gel column to give diol 12 (38 mg, 76%), colorless needles (from hexane). 
mp 192.5-193.2°C. IRvmax cm-1: 3650. 1H-NMR 8 (CDC13): 5.27, 5.25 (each 1H, s, 17-
H2), 4.26 (1H, s, 15-H), 3.88 (1H, d, J=5.1 Hz, 11-H), 2.78 (1H, br s, 13-H), 0.92, 0.89 and 
0.82 (each 3H, s, 3XCH3). High-resolution MSm/z; M+ Calcd for C20H32O2: 304.240. 
Found: 304.238. 
ent-lla-Hydroxykauren-15-one (3) 
   To a solution of 12 (9.2 mg) in CH2C12 (1 ml) was added maganese dioxide (49.8 mg) and 
the mixture was stirred for 3 days at room temperature. After filtration, the residue was 
washed with dichloromethane. The combined solution was evaporated off to give a residue 
which was chromatographed on a silica gel column to separate crystalline ketone 3 (3.4 mg, 
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37%). 
   The obtained ketone 3 was identified as  ent-11a-hydroxykauren-15-one" by the compari-
son of the IR and 1H—NMR data. 
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